Intense Pulsed Light Therapy with Optimal Pulse Technology as an Adjunct Therapy for Moderate to Severe Blepharitis-Associated Keratoconjunctivitis

PURPOSE: To evaluate the intense pulsed light (IPL) therapy with optimal pulse technology (OPT, M22™, Lumenis, USA) as an adjunct therapy for the prevention of recurrences in moderate to severe blepharokeratoconjunctivitis (BKC). METHODS: This open-label nonrandomized clinical trial evaluated 33 pat...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Ophthalmol
Päätekijät: Ruan, Fang, Zang, Yunxiao, Sella, Ruti, Lu, Hongshuang, Li, Shang, Yang, Ke, Jin, Tao, Afshari, Natalie A., Pan, Zhiqiang, Jie, Ying
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Hindawi 2019
Aiheet:
Clinical Study
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6766164/
https://ncbi.nlm.nih.gov/pubmed/31637051
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/3143469
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia